Adage Capital Partners’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2M | Buy |
+5,905,349
| New | +$30.2M | 0.05% | 350 |
|
|
2024
Q4 | – | Sell |
-2,294,206
| Closed | -$17.7M | – | 958 |
|
|
2024
Q3 | $17.7M | Hold |
2,294,206
| – | – | 0.03% | 481 |
|
|
2024
Q2 | $19.7M | Hold |
2,294,206
| – | – | 0.04% | 439 |
|
|
2024
Q1 | $18.2M | Sell |
2,294,206
-1,105,794
| -33% | -$8.78M | 0.03% | 477 |
|
|
2023
Q4 | $33.7M | Buy |
3,400,000
+1,645,148
| +94% | +$16.3M | 0.07% | 290 |
|
|
2023
Q3 | $19.8M | Buy |
1,754,852
+564,971
| +47% | +$6.36M | 0.04% | 396 |
|
|
2023
Q2 | $3.95M | Sell |
1,189,881
-1,800
| -0.2% | -$5.98K | 0.01% | 692 |
|
|
2023
Q1 | $4.71M | Sell |
1,191,681
-8,319
| -0.7% | -$32.9K | 0.01% | 715 |
|
|
2022
Q4 | $8.7M | Buy |
1,200,000
+200,000
| +20% | +$1.45M | 0.02% | 667 |
|
|
2022
Q3 | $3.62M | Hold |
1,000,000
| – | – | 0.01% | 813 |
|
|
2022
Q2 | $4.53M | Hold |
1,000,000
| – | – | 0.01% | 809 |
|
|
2022
Q1 | $7.58M | Buy |
+1,000,000
| New | +$7.58M | 0.01% | 770 |
|
|
2021
Q3 | – | Sell |
-500,000
| Closed | -$5.69M | – | 1068 |
|
|
2021
Q2 | $5.69M | Sell |
500,000
-100,000
| -17% | -$1.14M | 0.01% | 810 |
|
|
2021
Q1 | $6.67M | Hold |
600,000
| – | – | 0.01% | 765 |
|
|
2020
Q4 | $6.86M | Hold |
600,000
| – | – | 0.02% | 653 |
|
|
2020
Q3 | $6.22M | Buy |
+600,000
| New | +$6.22M | 0.02% | 599 |
|